Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Presentation of the Interim Report Q1, 2023 - Apr 27

Annual and Sustainability Report 2022

Latest CEO Comments

APRIL 27, 2023

"Navigating troubled waters"

Read the latest CEO comments from Nikolaj Sørensen

News flow

Regulatory Press Releases

Key financial figures

Group net revenue

623.7 MSEK
Last Twelve Months, Q222-Q123

Group EBITDA

-159.1 MSEK
Last Twelve Months, Q222-Q123

US Pharma segment EBIT

298.7 MSEK
Last Twelve Months, Q222-Q123

Cash position

278.9 MSEK
Q123
IR-Contact